BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10091686)

  • 1. Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region).
    Varie DL; Shih C; Hay DA; Andis SL; Corbett TH; Gossett LS; Janisse SK; Martinelli MJ; Moher ED; Schultz RM; Toth JE
    Bioorg Med Chem Lett; 1999 Feb; 9(3):369-74. PubMed ID: 10091686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel cryptophycin analogs with modification in the beta-alanine region.
    Shih C; Gossett LS; Gruber JM; Grossman CS; Andis SL; Schultz RM; Worzalla JF; Corbett TH; Metz JT
    Bioorg Med Chem Lett; 1999 Jan; 9(1):69-74. PubMed ID: 9990459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First generation design, synthesis, and evaluation of azepine-based cryptophycin analogues.
    Smith AB; Cho YS; Zawacki LE; Hirschmann R; Pettit GR
    Org Lett; 2001 Dec; 3(25):4063-6. PubMed ID: 11735585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis and anti-tubulin activity of epi-c3 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jul; 47(14):3697-9. PubMed ID: 15214797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
    Liang J; Moore RE; Moher ED; Munroe JE; Al-awar RS; Hay DA; Varie DL; Zhang TY; Aikins JA; Martinelli MJ; Shih C; Ray JE; Gibson LL; Vasudevan V; Polin L; White K; Kushner J; Simpson C; Pugh S; Corbett TH
    Invest New Drugs; 2005 Jun; 23(3):213-24. PubMed ID: 15868377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
    Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH
    J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total synthesis and antitubulin activity of c10 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jan; 47(3):696-702. PubMed ID: 14736249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total syntheses and biological investigations of tamandarins A and B and tamandarin A analogs.
    Liang B; Richard DJ; Portonovo PS; JoulliƩ MM
    J Am Chem Soc; 2001 May; 123(19):4469-74. PubMed ID: 11457232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halohydrin analogues of cryptophycin 1: synthesis and biological activity.
    Georg GI; Ali SM; Stella VJ; Waugh WN; Himes RH
    Bioorg Med Chem Lett; 1998 Aug; 8(15):1959-62. PubMed ID: 9873466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, conformational analysis, and cytotoxicity of new analogues of the natural cyclodepsipeptide jaspamide.
    Terracciano S; Bruno I; Bifulco G; Copper JE; Smith CD; Gomez-Paloma L; Riccio R
    J Nat Prod; 2004 Aug; 67(8):1325-31. PubMed ID: 15332850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cryptophycins: their synthesis and anticancer activity.
    Eggen M; Georg GI
    Med Res Rev; 2002 Mar; 22(2):85-101. PubMed ID: 11857635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
    Shih C; Teicher BA
    Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure--activity relationships of side-chain modified didemnins.
    Ding X; Vera MD; Liang B; Zhao Y; Leonard MS; JoulliƩ MM
    Bioorg Med Chem Lett; 2001 Jan; 11(2):231-4. PubMed ID: 11206466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptophycin affinity labels: synthesis and biological activity of a benzophenone analogue of cryptophycin-24.
    Vidya R; Eggen M; Georg GI; Himes RH
    Bioorg Med Chem Lett; 2003 Feb; 13(4):757-60. PubMed ID: 12639575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological property of carba and 20-deoxo analogues of arenastatin A.
    Murakami N; Wang W; Tamura S; Kobayashi M
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1823-6. PubMed ID: 10969977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis and Biological Evaluation of a Structurally Simplified Syringolin A Analogues.
    Chiba T; Kitahata S; Matsuda A; Ichikawa S
    Chem Pharm Bull (Tokyo); 2016; 64(7):811-6. PubMed ID: 27373636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A convergent synthesis of (+)-cryptophycin B, a potent antitumor macrolide from Nostoc sp. cyanobacteria.
    Ghosh AK; Bischoff A
    Org Lett; 2000 Jun; 2(11):1573-5. PubMed ID: 10841482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and cytostatic activities of didemnin derivatives.
    Schmidt U; Griesser H; Haas G; Kroner M; Riedl B; Schumacher A; Sutoris F; Haupt A; Emling F
    J Pept Res; 1999 Aug; 54(2):146-61. PubMed ID: 10461749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1.
    Panda D; Himes RH; Moore RE; Wilson L; Jordan MA
    Biochemistry; 1997 Oct; 36(42):12948-53. PubMed ID: 9335554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship study of syringolin A as a potential anticancer agent.
    Chiba T; Matsuda A; Ichikawa S
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4872-4877. PubMed ID: 26231162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.